Asia Pacific Overactive Bladder Treatment Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 Asia Pacific Overactive Bladder Treatment Market– By Disease Type

1.3.3 Asia Pacific Overactive Bladder Treatment Market – By Country

2. Asia Pacific Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. Overactive Bladder Treatment Market – Asia Pacific Analysis

6.1 Asia Pacific Overactive Bladder Treatment Market Revenue Forecast and Analysis

7. Asia Pacific Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 Asia Pacific Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation: Asia Pacific Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8. Asia Pacific Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 Asia Pacific Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

9.1 Overview

9.1.1 Asia Pacific: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.1.1 China: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1 China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 China: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.1.2.1 China: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.1.2.2 China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3 China: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.2 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Japan: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.2.2.1 Japan: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.2.2.2 Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3 Japan: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.3 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1 India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 India: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.3.2.1 India: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.3.2.2 India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3 India: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.4 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.2 South Korea: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.4.2.1 South Korea: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.4.2.2 South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3 South Korea: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.5 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.2 Australia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.5.2.1 Australia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.5.2.2 Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.3 Australia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.6 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.2 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.6.2.1 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.6.2.2 Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.3 Rest of Asia Pacific: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

10. Overactive Bladder Treatment Market– Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

11. Company Profiles

11.1 Alembic Pharmaceuticals Limited

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Astellas Pharma Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 AbbVie Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Teva Pharmaceutical Industries Ltd

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Endo Pharmaceuticals Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Hisamitsu Pharmaceutical Co.,Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Pfizer Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. China Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2. China Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 3. China Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. China Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. Japan Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. Japan Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 7. Japan Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. Japan Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. India Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10. India Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 11. India Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. India Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14. South Korea Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 15. South Korea Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 16. South Korea Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Australia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 18. Australia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 19. Australia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 20. Australia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Asia Pacific Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Asia Pacific Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 24. Rest of Asia Pacific Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Organic Developments Done by Companies

Table 26. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia Pacific Overactive Bladder Treatment Market Segmentation

Figure 2. Asia Pacific Overactive Bladder Treatment Market Segmentation, By Country

Figure 3. Asia Pacific Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Asia Pacific Overactive Bladder Treatment market

Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. Asia Pacific: PEST Analysis

Figure 8. Asia Pacific Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 9. Asia Pacific Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Asia Pacific Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 11. Mirabegron: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Botox: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Neurostimulation: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Transcutaneous Sacral Nerve Stimulation: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Transcutaneous Tibial Nerve Stimulation: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 16. Percutaneous Posterior Tibial Nerve: Asia Pacific Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Others: Asia Pacific Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18. Anticholinergics: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Solifenacin: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Oxybutynin: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Fesoterodine: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Darifenacin: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Tolterodine: Asia Pacific Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Trospium: Asia Pacific Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Other Anticholinergics: Asia Pacific Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Intravesical Instillation: Asia Pacific Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Asia Pacific Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 28. Idiopathic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Asia Pacific: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 31. China: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Japan: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. India: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. South Korea: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Australia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Rest of Asia Pacific: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)